Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease - eBioMedicine

Pathologically catalyzed physical coating restores the intestinal barrier for inflammatory bowel disease therapy, Journal of Nanobiotechnology

Pathologically catalyzed physical coating restores the intestinal barrier for inflammatory bowel disease therapy, Journal of Nanobiotechnology

Nutrients, Free Full-Text

Combining strategies to target inflammation, resolution and epithelial

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer, Journal of Translational Medicine

JCM, Free Full-Text

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer, Journal of Translational Medicine

JCM, Free Full-Text

Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

Evaluation of Intestinal Epithelial Barrier Function in Inflammatory Bowel Diseases Using Murine Intestinal Organoids. - Abstract - Europe PMC

Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli - ScienceDirect

Frontiers Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity

Intestinal barrier dysfunction orchestrates the onset of inflammatory host–microbiome cross-talk in a human gut inflammation-on-a-chip